DUBs and disease: activity assays for inhibitor development

Anitha Shanmugham1, Huib Ovaa

  • 1The Netherlands Cancer Institute, Division of Cellular Biochemistry, Plesmanlaan 121, Amsterdam, The Netherlands.

Current Opinion in Drug Discovery & Development
|August 30, 2008
PubMed

Insights

Deubiquitinating enzymes (DUBs) remove ubiquitin, impacting protein stability and disease processes like cancer. This review explores methods to study DUB activity and identify potential inhibitors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Deubiquitinating enzymes (DUBs) regulate protein stability by cleaving ubiquitin, influencing proteasomal degradation.
  • DUB activity is linked to diseases such as cancer and neurodegeneration, affecting oncogenic proteins and tumor suppressors.
  • Despite their importance, the selectivity and reactivity of DUBs within the ubiquitin-proteasome system remain poorly understood.

Purpose of the Study:

  • To review established in vitro methods for studying deubiquitinating enzyme (DUB) action.
  • To discuss the application of these methods in the discovery of DUB inhibitors.
  • To highlight the current gaps in understanding DUB selectivity and reactivity.

Main Methods:

  • Literature review of published in vitro assays for DUB activity.
  • Analysis of methods used for screening and characterizing DUB inhibitors.
  • Discussion of techniques applicable to studying DUB selectivity and kinetics.

Main Results:

  • Various in vitro methods exist to analyze DUB enzymatic activity.
  • These methods are crucial for identifying small molecules that modulate DUB function.
  • The review consolidates knowledge on studying DUBs, aiding future research.

Conclusions:

  • In vitro assays are essential tools for investigating deubiquitinating enzyme mechanisms.
  • Understanding DUBs is critical for developing targeted therapies for diseases like cancer.
  • Further research is needed to fully elucidate DUB selectivity and reactivity for improved therapeutic strategies.